title: Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
authors.forename: Hubertus
authors.initials: H
authors.lastname: Himmerich
authors.forename: Martin
authors.initials: M
authors.lastname: Ehrlinger
authors.forename: Melanie
authors.initials: M
authors.lastname: Hackenberg
authors.forename: Birgit
authors.initials: B
authors.lastname: Löhr
authors.forename: Thomas
authors.initials: T
authors.lastname: Nickel
mesh_terms: D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D003863:Depression / Q000188:drug therapy*; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D000069348:Quetiapine Fumarate; D012206:Rhabdomyolysis / Q000097:blood / Q000139:chemically induced*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D005473:Fluoxetine; D000069348:Quetiapine Fumarate; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D003402:Creatine Kinase